Coronary Bifurcation Stenting (COBIS) Registry in South Korea (COBIS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00851526|
Recruitment Status : Completed
First Posted : February 26, 2009
Last Update Posted : July 17, 2012
The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea.
The aim of the study was to find out the current status of bifurcation drug-eluting stenting and determine the prognostic factors for long-term outcome in South Korea.
|Condition or disease|
|Coronary Bifurcation Lesion|
|Study Type :||Observational|
|Actual Enrollment :||1919 participants|
|Official Title:||Coronary Bifurcation Stenting (COBIS) Registry in South Korea|
|Study Start Date :||January 2004|
|Actual Primary Completion Date :||December 2008|
|Actual Study Completion Date :||December 2008|
|Coronary bifurcation lesion|
- Incidence of the composite outcome of all-cause death, MI, or any PCI/CABG [ Time Frame: 3 years ]
- Incidence of stent thrombosis, and periprocedural MI [ Time Frame: 3 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00851526
|Korea, Republic of|
|Samsung Medical Center|
|Seoul, Korea, Republic of, 135-710|